Issue 6/2019
Content (9 Articles)
Migraine
Leading Article
Pathophysiological Mechanisms in Migraine and the Identification of New Therapeutic Targets
Kristian Agmund Haanes, Lars Edvinsson
Schizophrenia
Leading Article
The Possible Role of the Angiotensin System in the Pathophysiology of Schizophrenia: Implications for Pharmacotherapy
SeungJu Jackie Oh, Xiaoduo Fan
Schizophrenia
Systematic Review
Medication-Induced Akathisia with Newly Approved Antipsychotics in Patients with a Severe Mental Illness: A Systematic Review and Meta-Analysis
Koen Demyttenaere, Johan Detraux, Giorgio Racagni, Kristof Vansteelandt
Naloxone
Review Article
Buprenorphine Treatment for Opioid Use Disorder: An Overview
Matisyahu Shulman, Jonathan M. Wai, Edward V. Nunes
Antidepressant Drugs
Original Research Article
Association of Hyponatraemia and Antidepressant Drugs: A Pharmacovigilance–Pharmacodynamic Assessment Through an Analysis of the US Food and Drug Administration Adverse Event Reporting System (FAERS) Database
Faizan Mazhar, Marco Pozzi, Marta Gentili, Marco Scatigna, Emilio Clementi, Sonia Radice, Carla Carnovale
Pharmacokinetics and Tolerability of Multiple Doses of Pharmaceutical-Grade Synthetic Cannabidiol in Pediatric Patients with Treatment-Resistant Epilepsy
James W. Wheless, Dennis Dlugos, Ian Miller, D. Alexander Oh, Neha Parikh, Steven Phillips, J. Ben Renfroe, Colin M. Roberts, Isra Saeed, Steven P. Sparagana, Jin Yu, Maria Roberta Cilio
Pharmacodynamics
Original Research Article
Safety, Pharmacokinetics and Pharmacodynamics of TNHH, a Novel Targeted Neutrophil-Inhibitory Hirulog Hybrid Glycoprotein, in Healthy Volunteers
Zhong Ping Gou, Zi Hui Song, Xiao Gang Chen, Xiao Cheng Hu, Ying Wang, Kai Fan, Yong Ming Cai, Li Zheng
Migraine
Letter to the Editor
Comment on: “Phytomedicines in the Treatment of Migraine”
Hans-Christoph Diener
Migraine
Letter to the Editor
Authors’ Reply to Diener: “Phytomedicines in the Treatment of Migraine”
Thilinie Rajapakse, William Jeptha Davenport